NCT01364857 2025-12-22
CONAPE
University Hospital, Tours
Phase NA Completed
Clinical Trials
11 trialsNCT04517565 2025-07-15
Longitudinal Neuroimaging in Sturge-Weber Syndrome
Wayne State University
Phase NA Recruiting
NCT05495269 2025-01-20
Safety and Tolerability Study of QLS-101 in Adolescents With Sturge-Weber Syndrome (SWS)-Related Glaucoma Due to Elevated Episcleral Venous Pressure (EVP)
Qlaris Bio, Inc.
Phase 2 Completed
NCT04344626 2023-10-10
Use of a Tonometer to Identify Epileptogenic Lesions During Pediatric Epilepsy Surgery
University of California, Los Angeles
Phase NA Withdrawn
NCT04447846 2023-05-25
Novel Cognitive Treatment Targets for Epidiolex in Sturge- Weber Syndrome
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Phase 2 Completed
NCT02332655 2022-03-02
Cannabidiol Expanded Access Study in Medically Refractory Sturge-Weber Syndrome
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Phase 1/2 Completed
NCT04999618 2021-11-04
DOUBLE-SKIN
Center for Vascular Pathology, Moscow
Phase 4 Completed
NCT03047980 2021-11-01
Trial of Sirolimus for Cognitive Impairment in Sturge-Weber Syndrome
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Phase 2/3 Completed
NCT01533376 2019-03-21
Treatment of Port-wine Mark in Sturge-Weber Syndrome Using Topical Timolol
Wills Eye
Phase 1 Terminated
NCT01997255 2016-05-05
Adjunctive Everolimus (RAD 001) Therapy for Epilepsy in Children With Sturge-Weber Syndrome (SWS)
Baylor College of Medicine
Phase 2 Withdrawn
NCT00639730 2010-05-27
Use of the Atkins Diet for Children With Sturge Weber Syndrome
Johns Hopkins University
Phase 1 Completed